Publications by authors named "M Kele"

Preclinical transplantations using human neuroepithelial stem (NES) cells in spinal cord injury models have exhibited promising results and demonstrated cell integration and functional improvement in transplanted animals. Previous studies have relied on the generation of research grade cell lines in continuous culture. Using fresh cells presents logistic hurdles for clinical transition regarding time and resources for maintaining high quality standards.

View Article and Find Full Text PDF

We have developed an efficient approach to generate functional induced dopaminergic (DA) neurons from adult human dermal fibroblasts. When performing DA neuronal conversion of patient fibroblasts with idiopathic Parkinson's disease (PD), we could specifically detect disease-relevant pathology in these cells. We show that the patient-derived neurons maintain age-related properties of the donor and exhibit lower basal chaperone-mediated autophagy compared with healthy donors.

View Article and Find Full Text PDF

CASK-related disorders are genetically defined neurodevelopmental syndromes. There is limited information about the effects of CASK mutations in human neurons. Therefore, we sought to delineate CASK-mutation consequences and neuronal effects using induced pluripotent stem cell-derived neurons from two mutation carriers.

View Article and Find Full Text PDF

Background: Down syndrome (DS) is characterized by neurodevelopmental abnormalities caused by partial or complete trisomy of human chromosome 21 (T21). Analysis of Down syndrome brain specimens has shown global epigenetic and transcriptional changes but their interplay during early neurogenesis remains largely unknown. We differentiated induced pluripotent stem cells (iPSCs) established from two DS patients with complete T21 and matched euploid donors into two distinct neural stages corresponding to early- and mid-gestational ages.

View Article and Find Full Text PDF
Article Synopsis
  • The study utilized single-cell RNA sequencing to analyze various human induced pluripotent stem (iPS) cell-derived neural stem cell (NSC) lines and a fetal brain-derived NSC line, focusing on cell type heterogeneity during the proliferating stage of NSCs.
  • Researchers discovered distinct heterogeneity among neurogenic progenitors from iPS-derived NSCs compared to the fetal-derived NSC line, highlighting differences in their differentiation potential for inhibitory and excitatory neurons.
  • The study also implemented a glia patterning protocol to enrich gliogenic progenitors, successfully generating glial cells from an iPS-derived NSC line.
View Article and Find Full Text PDF